SPR Therapeutics to Receive $1.45M Grant from National Institutes of Health

Cleveland-based SPR Therapeutics will receive a $1.45 million grant from the NIH that it will use to develop an implantable version of its nerve stimulation system, used to treat post-amputation pain.

Read More  >